Literature DB >> 25411101

Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.

Maria Ida Maiorino1, Giuseppe Bellastella, Michela Petrizzo, Elisabetta Della Volpe, Rosanna Orlando, Dario Giugliano, Katherine Esposito.   

Abstract

Circulating endothelial progenitor cells (EPCs) are bone marrow-derived stem cells able to migrate to sites of damaged endothelium and differentiate into endothelial cells, thereby contributing to vascular repair. Recent studies demonstrated a reduction of EPCs in patients with diabetes mellitus or erectile dysfunction (ED). The aim of this study was to evaluate the circulating levels of different EPCs phenotypes and their relation with testosterone levels in young type 1 diabetic patients with ED. We studied 118 consecutively type 1 diabetic patients and 60 age-matched healthy controls. Erectile function was assessed by completing the International Index of Erectile Function (IIEF-5) and EPCs levels by flow cytometry. Testosterone concentrations were evaluated in all the study population. We identified 38 diabetic patients with ED (Group 1) and 80 patients without ED (Group 2). CD34+KDR+CD133+ cells were significantly lower in patients in Group 1 as compared with those in Group 2 [median and interquartile range, n/10(6) events, 12 (6-16) vs. 18 (13-22), P < 0.001)]. In all participants in the study, there was a significant correlation between circulating CD34+KDR+CD133+ cells and testosterone levels (r = 0.410, P < 0.001), which was highest in Group 1, intermediate in Group 2, and lowest in Group 3 (controls). There was a significant correlation between IIEF-5 score and both CD34+KDR+ (r = 0.459, P = 0.003) and CD34+KDR+CD133+ (r = 0.316, P = 0.050) cells among patients of Group 1, as well as between testosterone levels and most of the EPCs phenotypes. Finally, multivariate regression analysis identified levels of circulating CD34+KDR+ cells as an independent risk factor for ED (β-coefficient 0.348, P = 0.007). In conclusion, type 1 diabetic patients with ED show reduced levels of CD34+KDR+CD133+ cells, whose number correlates with IIEF. Further studies are needed to fully understand the exact mechanisms by which testosterone regulates vascular homeostasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25411101     DOI: 10.1007/s12020-014-0478-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Identification of late-onset hypogonadism in middle-aged and elderly men.

Authors:  Frederick C W Wu; Abdelouahid Tajar; Jennifer M Beynon; Stephen R Pye; Alan J Silman; Joseph D Finn; Terence W O'Neill; Gyorgy Bartfai; Felipe F Casanueva; Gianni Forti; Aleksander Giwercman; Thang S Han; Krzysztof Kula; Michael E J Lean; Neil Pendleton; Margus Punab; Steven Boonen; Dirk Vanderschueren; Fernand Labrie; Ilpo T Huhtaniemi
Journal:  N Engl J Med       Date:  2010-06-16       Impact factor: 91.245

2.  Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.

Authors:  Katherine Esposito; Miryam Ciotola; Maria Ida Maiorino; Francesco Giugliano; Riccardo Autorino; Marco De Sio; Emmanuele Jannini; Andrea Lenzi; Dario Giugliano
Journal:  J Sex Med       Date:  2009-01       Impact factor: 3.802

3.  Circulating endothelial progenitor cells in subjects with erectile dysfunction.

Authors:  C Foresta; N Caretta; A Lana; A Cabrelle; G Palù; A Ferlin
Journal:  Int J Impot Res       Date:  2005 May-Jun       Impact factor: 2.896

4.  Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.

Authors:  Caroline Schmidt-Lucke; Lothar Rössig; Stephan Fichtlscherer; Mariuca Vasa; Martina Britten; Ulrike Kämper; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

Review 5.  The link between erectile and cardiovascular health: the canary in the coal mine.

Authors:  David R Meldrum; Joseph C Gambone; Marge A Morris; Donald A N Meldrum; Katherine Esposito; Louis J Ignarro
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

6.  Reduced number of circulating endothelial progenitor cells in hypogonadal men.

Authors:  C Foresta; N Caretta; A Lana; L De Toni; A Biagioli; A Ferlin; A Garolla
Journal:  J Clin Endocrinol Metab       Date:  2006-08-22       Impact factor: 5.958

Review 7.  Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.

Authors:  Shaundeep Sen; Stephen P McDonald; P Toby H Coates; Claudine S Bonder
Journal:  Clin Sci (Lond)       Date:  2011-04       Impact factor: 6.124

8.  Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici.

Authors:  D Fedele; C Coscelli; F Santeusanio; A Bortolotti; L Chatenoud; E Colli; M Landoni; F Parazzini
Journal:  Diabetes Care       Date:  1998-11       Impact factor: 19.112

Review 9.  Erectile dysfunction as a cardiovascular risk factor in patients with diabetes.

Authors:  Giorgio Gandaglia; Andrea Salonia; Niccolò Passoni; Piero Montorsi; Alberto Briganti; Francesco Montorsi
Journal:  Endocrine       Date:  2012-09-05       Impact factor: 3.633

10.  Endothelial impairment and bone marrow-derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction.

Authors:  Miho Murata; Hiroyuki Tamemoto; Taeko Otani; Sachimi Jinbo; Nahoko Ikeda; Masanobu Kawakami; San-E Ishikawa
Journal:  J Diabetes Investig       Date:  2012-07-24       Impact factor: 4.232

View more
  11 in total

1.  Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study.

Authors:  Maria Ida Maiorino; Ofelia Casciano; Elisabetta Della Volpe; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2015-07-17       Impact factor: 3.633

Review 2.  Molecular mechanisms associated with diabetic endothelial-erectile dysfunction.

Authors:  Ângela Castela; Carla Costa
Journal:  Nat Rev Urol       Date:  2016-02-16       Impact factor: 14.432

Review 3.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

4.  Gender-differences in glycemic control and diabetes related factors in young adults with type 1 diabetes: results from the METRO study.

Authors:  Maria Ida Maiorino; Giuseppe Bellastella; Ofelia Casciano; Michela Petrizzo; Maurizio Gicchino; Mariangela Caputo; Annalisa Sarnataro; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2018-02-17       Impact factor: 3.633

Review 5.  Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome.

Authors:  Rocio de la Iglesia; Viviana Loria-Kohen; Maria Angeles Zulet; Jose Alfredo Martinez; Guillermo Reglero; Ana Ramirez de Molina
Journal:  Int J Mol Sci       Date:  2016-11-10       Impact factor: 5.923

6.  Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction.

Authors:  Junyi Shen; Zhiming Zhao; Wei Shang; Chunli Liu; Beibei Zhang; Lingjie Zhao; Hui Cai
Journal:  Int J Nanomedicine       Date:  2017-09-05

7.  Combined Transplantation of Adipose Tissue-Derived Stem Cells and Endothelial Progenitor Cells Improve Diabetic Erectile Dysfunction in a Rat Model.

Authors:  Qiyun Yang; Wanmei Chen; Chi Zhang; Yun Xie; Yong Gao; Cuncan Deng; Xiangzhou Sun; Guihua Liu; Chunhua Deng
Journal:  Stem Cells Int       Date:  2020-07-03       Impact factor: 5.443

8.  Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction.

Authors:  Mark Bieri; Elias Said; Gabrielle Antonini; Donald Dickerson; Jorge Tuma; Courtney E Bartlett; Amit N Patel; Alexander Gershman
Journal:  J Transl Med       Date:  2020-01-14       Impact factor: 5.531

9.  Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase.

Authors:  Yan Zhang; Zhi Chen; Tao Wang; Jun Yang; Rui Li; Shaogang Wang; Jihong Liu; Zhangqun Ye
Journal:  Oncotarget       Date:  2016-06-28

10.  Combination of low-energy shock-wave therapy and bone marrow mesenchymal stem cell transplantation to improve the erectile function of diabetic rats.

Authors:  Hai-Tao Shan; Hai-Bo Zhang; Wen-Tao Chen; Feng-Zhi Chen; Tao Wang; Jin-Tai Luo; Min Yue; Ji-Hong Lin; An-Yang Wei
Journal:  Asian J Androl       Date:  2017 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.